ScripNovo Nordisk has just presented two successful cardiovascular-focused Phase III studies of semaglutide, but analysts think they will not be enough to stop Eli Lilly’s rival, tirzepatide, from dominati
In VivoPfizer was the biggest company in the world by pharmaceutical sales in 2024. Among the rest of the top five there was change, however, as Merck & Co climbed above Johnson & Johnson and AbbVie
ScripBig Pharma’s global capability centers (GCCs) in India are evolving well beyond being just “cost efficiency outposts” and transitioning, in some cases, to emerge as centers of excellence (CoEs) unlock
ScripThe hemophilia market is a challenging and competitive field but Sanofi is confident that fitusiran, which has just been given the green light by the US Food and Drug Administration (28 March), has th